Thursday, 24 April 2014

Comvita Limited

NZX : CVT

3.180
24 Apr 14 00:00
Change:
 0.04
Open:
3.180
High:
3.180
Ask:
3.150
Volume:
155
Change(%):
1.24
Prev:
3.220
Low:
3.180
Bid:
3.050
Avg vol:
0
Profile
Comvita Limited engages in the manufacture and marketing of natural health products. The company offers functional food, health care, personal care, and medical products. Its product portfolio includes antioxidants, apple cider vinegar, bee pollen, colostrum, honey, herbal extracts, manuka honey, nutritional oil, olive leaf complex, propolis, royal jelly, skincare, winter wellness, and wound care products. The company operates primarily in New Zealand, Australia, Asia, North America, the United Kingdom, and rest of Europe. Comvita Limited was founded in 1974 and is based in Te Puke, New Zealand.
Summary
Shares:31,714,730
Issuer:Comvita Limited
Solicitor:Sharp Tudhope
Registry:LINK MARKET SERVICES LIMITED
Auditor:KPMG Tauranga
Settlement:NZCDC Settlement System
Website:http://www.comvita.com/
Fundamentals
Market Cap:$100,852,841
52 wk High:4.250
52 wk Low:3.400
Sector:Consumer
Div/Yield:5.710
EPS:0.041
Price/Earnings:36.790
NTA:0.645
Address
Comvita Limited
Wilson Road South
Paengaroa
Te Puke,
New Zealand
Latest News
  • Rumor: Ratchet & Clank Trilogy Headed To PlayStation Vita

    03:51 | 9/4/14
    PSX Extreme
    Yor you guys who have been inquiring about the Vita's Borderlands 2 Limited Edition bundle, it will be coming out this May 6th. more»
  • Patent Applicant Claims Olive Polyphenols Help Blood Sugar Control

    13:33 | 2/4/14
    Olive Oil Times
    Comvita Ltd subsidiary Apimed Medical Honey Ltd, based in New Zealand, said in its patent application before the World Intellectual Property Organization that in a double blind, placebo controlled trial involving 46 overweight middle-aged men at risk ... more»
  • Derma Sciences Inc (DSCI) news: Derma Sciences' CEO Discusses Q4 2013 ...

    09:37 | 15/3/14
    Seeking Alpha
    Factors that may affect the company's results include, but are not limited to product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of ... more»
  • Derma Sciences Reports Fourth Quarter Financial Results, Provides ...

    00:26 | 15/3/14
    Wall Street Journal
    As of December 31, 2013, Derma Sciences had cash, cash equivalents and investments of $23.0 million (excluding a $6.9 million investment in Comvita common stock held as a long-term investment), compared with $45.8 million as of December 31, 2012 ... more»
  • Project celebrates 10 years

    15:26 | 14/3/14
    SunLive
    Other organisations that have also made significant contributions to the restoration project include Te Runanga O Te Ngai Tamarawaho, Comvita, Legacy Funerals, Trees for Survival, Opus International Ltd and Naturally Native NZ Plants. The restoration ... more»
Announcements
There are currently no comments on this topic.
Be the first person to Add a Comment...
Add a Comment
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
Global Indices
CodeLastChange
NZ505,154110.22%
COMP4,127340.83%
DJI16,502130.08%
SP5001,87540.22%
DAX9,544560.58%
FTSE6,67570.11%
NI22514,4231230.85%
TWI80.020.250.31%
Currencies
CodeLastChange
EURUSD1.3820.0000.03%
NZDUSD0.86270.00210.24%
AUDUSD0.92970.00110.12%
NZDAUD0.92790.00140.15%